Ro.co vs HealthRx: Wegovy pill vs compounded GLP-1 plans

Ro.co vs HealthRx is a contrast between access to an FDA-approved oral GLP-1 and lower-cost compounded GLP-1 plans. Quick verdict: choose Ro.co if you want access to the Wegovy pill, an FDA-approved oral option and finished medication; choose HealthRx if you prioritize lower advertised monthly pricing on compounded semaglutide or tirzepatide with prepaid plans and overnight cold shipping.

Start with Ro.co for Wegovy access

How pricing and plans compare

Ro.co advertises you can “Get Started Online for Just $39,” with ongoing branded medication pricing varying by plan and medication. HealthRx lists plans “from $99/month on a 12-month prepaid semaglutide plan ($1,163 today; $1,188 at renewal)” and tirzepatide plans starting at $179/month. HealthRx notes the lowest advertised monthly price requires a longer prepaid plan. Treatment with either provider is available only when a licensed clinician determines it is medically appropriate.

Get started with Ro.co from $39

Medication type and regulatory status

Ro.co is presented as the only mainstream platform in this comparison offering the Wegovy pill, the first and only FDA-approved oral GLP-1 weight loss medication, and it emphasizes that it prescribes FDA-approved finished medication rather than compounded products. HealthRx offers compounded semaglutide or tirzepatide “prepared per prescription” in a licensed 503A pharmacy cleanroom and states clearly that compounded medication is not FDA-approved and is not reviewed by FDA for safety, effectiveness or quality.

Delivery, dosing, and clinician review

HealthRx highlights overnight cold shipping with tracked, free shipping on every plan and says dose adjustments do not change the plan price. Both platforms require clinician review: HealthRx says the clinician decides whether semaglutide or tirzepatide is the right fit or whether neither is; Ro.co states treatment is available only when a licensed clinician determines it is medically appropriate.

See HealthRx prepaid plan details

Distinctive differences at a glance

Safety and regulatory notes

Both entries include the explicit regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co emphasizes that its Wegovy pill is an FDA-approved finished product, while HealthRx reiterates that its compound is prepared in a licensed 503A pharmacy cleanroom but is not FDA-approved.

Summary and who each provider suits

Ro.co vs HealthRx boils down to a trade-off between FDA-approved oral medication and lower-cost compounded plans with prepaid pricing and overnight shipping. Ro.co offers access to the Wegovy pill and emphasizes finished, FDA-approved medications and transparent upfront pricing starting at $39. HealthRx offers compounded semaglutide or tirzepatide plans starting at $99/month on a 12-month prepaid plan, with overnight cold shipping and stable plan pricing despite dose changes. Both require clinician review for treatment eligibility.

Compare HealthRx compounded plan options

Choose Ro.co for FDA-approved oral GLP-1

Choose Ro.co if…

You want access to the Wegovy pill, an FDA-approved oral GLP-1 finished medication and a platform that emphasizes branded, regulator-evaluated products and transparent starting pricing of $39.

Choose HealthRx if…

You prioritize lower advertised monthly pricing on compounded semaglutide or tirzepatide with a 12-month prepaid option, overnight cold shipping, and a plan where dose changes do not change the plan price. Confirm eligibility, pharmacy details, state availability and renewal terms before enrolling.

Primary keyword: Ro.co vs HealthRx